Pancreatitis clinical trials at UCSF
2 in progress, 0 open to new patients
-
A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis
Sorry, not yet accepting patients
Determine if IV ketorolac is an effective agent in the prevention of post-ERCP pancreatitis. Determine if IV ketorolac provides improved post-procedure analgesia. Determine if systemic mediators of inflammation are reduced in patients receiving IV ketorolac following ERCP.
San Francisco, California and other locations
-
Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation
Sorry, in progress, not accepting new patients
The study will be a phase 2/3, multicenter, double-blind, parallel assignment study. It will involve 100 adult recipients of an intra-hepatic pancreatic Islet Auto-Transplantation (IAT). The objective of this clinical trial is to assess whether reparixin leads to improved transplant outcome as measured by the proportion of insulin-independent patients following IAT. The safety of reparixin in the specific clinical setting will be also evaluated.
San Francisco, California and other locations